Psychiatry, as a distinct branch of medicine, has come far in its short life span. (The term psychiatrist is less than 150 years old.) The field has rejected the famously horrific practices of the recent past—the lobotomies, forced sterilizations, human warehousing. Today’s psychiatric practitioners boast a varied arsenal of effective drugs and have largely dropped the unscientific trappings of psychoanalytic psychobabble, the “schizophrenogenic mothers” of yesteryear who had been thought to have somehow triggered insanity in their unwitting offspring. Two decades into the 21st century, psychiatry now views severe mental illnesses as legitimate brain diseases. Despite all these advancements, however, the field still relies solely on self-reported symptoms and observable signs for diagnosis. Though the American Psychiatry Association reassures us that psychiatrists are uniquely qualified to “assess both the mental and physical aspects of psychological problems,” they are, like all of medicine, limited by the tools at hand. There are not, as of this writing, any consistent objective measures that can render a definitive psychiatric diagnosis.
For new patients, whose visits entail more work than those of established patients, 
The plot line of The Farewell is familiar to me. Like Billi’s Nai Nai, my aunt was diagnosed with metatastic lung cancer. Nobody in the family told her – nor did the doctors when she later underwent surgery to remove a tumour. The last time I saw her was in north-eastern China a few years ago. Her once-plump figure had shrunk to a wiry frame. She was in her early 70s, in good spirits, but a far cry from the feisty matriarch who used to dominate conversations.
The tool is simply called Preventive Health, and is now available to Facebook users in the United States. It takes a user’s age and sex from their Facebook profile and provides them with a list of recommended screenings based on those two data points.
LSE developed the survey to target four key groups:
In the survey analysis we highlight the behavioural element first, giving prominence to the voices and experiences of people living with dementia as direct assessment of actual behaviour is central to discrimination and is the closest representation of the true impact of stigma on people living with dementia.
The current study points to the role of norepinephrine, a neurotransmitter that signals arousal and stress in the central nervous system. This chemical is present in low levels in the brain while we sleep, but when production ramps up it arouses our nerve cells, causing us to wake up and become alert. The study showed that norepinephrine also acts on a specific receptor, the beta2 adrenergic receptor, which is expressed at high levels in microglia. When this chemical is present in the brain, the microglia slip into a sort of hibernation.
The prototype revealed that using artificial intelligence and machine learning to examine certain combinations of vital signs and other biomarkers could strongly 
“The risk for dementia is elevated about twofold in people who have diabetes or 
Boomers Daily 